P
US8524497B2ExpiredUtilityPatentIndex 91

Animal protein free media for cultivation of cells

Assignee: REITER MANFREDPriority: Jul 9, 2002Filed: May 6, 2011Granted: Sep 3, 2013
Est. expiryJul 9, 2022(expired)· nominal 20-yr term from priority
Inventors:REITER MANFREDMUNDT WOLFGANGGRILLBERGER LEOPOLDKRAUS BARBARA
C12N 2500/74C12N 7/00C12N 5/0043C12N 2770/36134A61K 39/145A61K 39/275C12N 2760/16134A61P 31/14C12N 2710/24134A61P 31/16A61P 37/02A61K 39/285C12N 5/005C12N 2500/76A61K 39/12Y02A50/30
91
PatentIndex Score
28
Cited by
196
References
12
Claims

Abstract

The present invention relates to animal protein free cell culture media comprising a combination of non-animal derived peptides derived from soy hydrolysate and yeast hydrolysate. The invention also provides an animal protein free culture process, wherein cells are cultivated, propagated and passaged without animal-derived components. This process is useful for cultivating cells, such as recombinant cells or cells infected with a virus, and for production biological products by cell culture processes under conditions devoid of animal protein components.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method of cultivating mammalian surface-dependent cells to obtain a confluent cell culture, comprising:
 providing an animal protein-free medium comprising soy hydrolysate at a concentration of about 0.05% (w/v) to about 1% (w/v) and yeast hydrolysate at a concentration of about 0.05% (w/v) to about 0.3% (w/v); 
 growing the surface-dependent cells in the medium; and 
 passaging and sub-cultivating the cells grown in the medium in order to obtain a confluent cell culture; 
 wherein the cells are infected with an orthomyxovirus and are selected from the grouping consisting of BSC-1 cells, CV-1 cells, COS cells, VERO cells, MDBK cells, MDCK cells, MDOK cells, BHK-21 cells, WI-38 cells, and MRC-5 cells. 
 
     
     
       2. The method of  claim 1 , wherein the cells are recombinant cells. 
     
     
       3. The method of  claim 1 , wherein the virus is an influenza virus. 
     
     
       4. The method of  claim 1 , wherein the step of passaging and sub-cultivating the cells further comprises contacting the cells with a non-animal protease, wherein the protease is a purified trypsin-like fraction of  Strepomyces griseus  (SGT). 
     
     
       5. The method of  claim 1 , wherein the soy hydrolysate is present in a concentration of between about 0.2% (w/v) to about 0.6% (w/v) and the yeast hydrolysate is present in a concentration of between about 0.05% (w/v) to about 0.2% (w/v). 
     
     
       6. The method of  claim 1 , wherein the soy hydrolysate is present in a concentration of between about 0.25% (w/v) to about 0.35% (w/v) and the yeast hydrolysate is present in a concentration of between about 0.05% (w/v) to about 0.15% (w/v). 
     
     
       7. The method of  claim 1 , wherein the soy hydrolysate is present in a concentration of about 0.3% (w/v) and the yeast hydrolysate is present in a concentration of about 0.1% (w/v). 
     
     
       8. The method of  claim 1 , wherein 3 parts by weight soy hydrolysate are present to 1 part of weight yeast hydrolysate. 
     
     
       9. The method of  claim 1 , wherein the yeast hydrolysate is an ultrafiltered purified yeast hydrolysate, and wherein at least 40% of said yeast hydrolysate has a molecular weight of less than or equal to 500 Daltons. 
     
     
       10. The method of  claim 1 , wherein the soy hydrolysate is an ultrafiltered purified soy hydrolysate, and wherein at least 40% of said soy hydrolysate has a molecular weight of less than or equal to 500 Daltons. 
     
     
       11. The method of  claim 1 , wherein the cells grow on a carrier. 
     
     
       12. The method of  claim 10 , wherein the carrier is a synthetic carrier, or a microcarrier coated with a non-animal material.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.